5 Stocks Targeted By Short Sellers Recently

2. Tenax Therapeutics, Inc. (NASDAQ:TENX)

Change In Short Interest Percentage: 18.71

Tenax Therapeutics, Inc. (NASDAQ:TENX) is a biotechnology firm headquartered in Chapel Hill, North Carolina. It develops treatments for people suffering from complications of heart disease. As of March 15, 2023, 2.16 million shares are short, up from the prior month’s 363,420.

By the end of last year’s fourth quarter, just one of the 943 hedge funds polled by Insider Monkey had bought Tenax Therapeutics, Inc. (NASDAQ:TENX)’s shares. The lone investor is Jim Simons’ Renaissance Technologies which owns 63,362 shares that are worth $7,000.

Follow Tenax Therapeutics Inc. (NASDAQ:TENX)